22053. Adulteration and misbranding of tincture of aconite, cinchophen facts, aromatic spirits of ammonia, and mineral oil. V. S. v. Gibson-Howell Co., Inc. Plea of guilty. Fine, $600. (F. & D. no. 30316. Sample nos. 10221-A, 10225-A, 21655-A, 21657-A, 21671-A, 31656-A.) f This case was based on interstate shipments of tincture of aconite, aromatic spirits of ammonia, and alleged heavy mineral oil, which differed from the standard established by the United States Pharmacopoeia, and of a shipment of cinchophen tablets which contained less cinchophen than declared on the label. The mineral oil was falsely branded as to the name of the manufacturer and place of manufacture. On April 6, 1934, the United States attorney for the District of New Jersey, acting upon a report by the Secretary of Agriculture, filed in the district court an information against the Gibson-Howell Co., Inc., a corporation, Jersey City, N. J., alleging shipment by said company, in violation of the Food and Drugs Act, between the dates of January 14 and March 24, 1933, from the State of New Jersey into the State of New York, of quantities of tincture of aconite, cinchophen tablets, aromatic spirits of ammonia, and mineral oil which were adulterated and misbranded. The articles were labeled, variously: " Tincture of Aconite U. S. P. * * * Prepared for Whelan Drug Company, Inc., New York"; "Cinchophen (Phenylcinchoninic acid) * * * 7% gr. * * * Distributed by Whelan Laboratories, Inc., New York"; " Honor Pycchoe Macho * * * Imported Russian Mineral Oil * * „* Honor Re- search Laboratories, New York * * * Heavy Genuine Imported"; "Aro- matic Spirits Ammonia U. S. P. * * * Distributed By Whelan Labora- tories, Inc., New York." It was alleged in the information that the tincture of aconite, aromatic spirits ammonia, and mineral oil were adulterated in that they were sold under names recognized in the United States Pharmacopoeia and differed from the standard of strength, quality, and purity as determined by the tests laid down in the said pharmacopoeia official at the time of investigation, in the following respects: The tincture of aconite, when administered subcutaneously to guinea pigs had a minimum lethal dose of not less than 0.0015 cc for each gram of body weight of guinea pig, whereas the pharmacopoeia provides that tincture of aconite shall have a minimum lethal dose of not more than 0.00045 cc for each gram of body weight of guinea pig; the aromatic spirits amonia contained less than 90 cc of ammonia water per 1,000 cc, samples from the two shipments having been found to contain not more than 70.54 and 72.88 cc, respectively, of ammonia water per 1,000 cc, whereas the pharmacopoeia provides that 1,000 cc of aromatic spirits of ammonia shall contain not less than 90 cc of am* monia water; the alleged heavy mineral oil had a kinetic viscosity of not more than 0.171 at 27.8° C, whereas the pharmacopoeia provides that heavy mineral oil shall have a kinetic viscosity of not less than 0.381 at 37.8?; and the standard of strength, quality, and purity of the articles was not declared on the containers thereof. Adulteration was alleged with respect to all prod- ucts for the reason that their strength and purity fell below the professed standard and quality under which they were sold in that the tincture of aconite and aromatic spirits ammonia were represented to conform to the standard laid down in the pharmacopoeia; whereas they did not conform to the standard laid down in that authority; the mineral oil was represented to be heavy Russian mineral oil, whereas it was not heavy Russian mineral oil, and the cinchophen tablets were represented to contain 7% grains of cinchophen per tablet, whereas they contained not more than 6.27 grains of cinchophen per tablet. Misbranding was alleged for the reason that the statements, "Tincture of Aconite U. S. P.", " Cinchophen * * * Tablets—7*4 gr.", "Aromatic Spirits Ammonia U. S. P.", "Russian Mineral Oil, Heavy * * * Honor Research Laboratories, New York, Chicago ", in the labeling were false and misleading, since the said statements represented that the tincture of aconite and aromatic spirits of ammonia conformed to the standard laid down in the United States Pharmacopoeia, that the cinchophen tablets contained 7% grains of cinchophen each, and that the mineral oil was heavy Russian mineral oil manufactured by the Honor Research Laboratories; whereas the tincture of aconite and aromatic spirits ammonia did not conform to the standard laid down in the pharmacopoeia, the cinchophen tablets contained less than 7% grains of cincho- phen, and the mineral oil was not Russian Mineral Oil Heavy, and was not manufactured by the Honor Research Laboratories, New York and Chicago. Misbranding of the mineral oil was alleged for the further reason that it was falsely branded as to the country in which it was manufactured and produced in that it was represented to have been manufactured and produced by the Honor Research Laboratories, New York and Chicago, whereas it was manu- factured and produced by the Gibson-Howell Sales Co., Jersey City, N. J. On June 28, 1934, a plea of guilty was entered on behalf of the defendant company, and the court imposed a fine of $600. M. L. WILSON, Acting Secretary of Agriculture.